GLP-1 and Spine Surgery: The Practical Protocol for Patients Who Take Semaglutide or Tirzepatide

GLP-1 and Spine Surgery: The Step-by-Step Protocol Every Patient on Semaglutide or Tirzepatide Needs Before Going Under the Knife

Here is the thing most surgeons and patients both get wrong: they assume being on Ozempic or Mounjaro automatically makes surgery riskier. A newly published study says that assumption may not hold up — at least for spine surgery. But "your outcomes look similar" does not mean "just show up and say nothing."

The research is reassuring. The preparation still requires a plan. This article gives you both.

Important: I'm not a doctor. Everything shared here is based on published research and general educational information. Talk to your surgeon and prescribing physician before making any changes to your GLP-1 regimen around surgery.

---

The Bottom Line

• New research found that patients on GLP-1 receptor agonists had similar spine surgery outcomes — including complications, hospital stay, and reoperation rates — compared to patients not on these medications. (Source: PubMed, PMID 41483457)
• That does NOT mean you skip the prep. GLP-1s slow digestion, which creates a real aspiration risk under anesthesia. This is the most important thing to manage.
• The standard "stop 24 hours before" rule is outdated for GLP-1 users. Many anesthesiologists now recommend stopping 1–2 weeks before elective procedures, depending on dose and procedure type.
• Specific numbers matter: Weekly injectable GLP-1s (like semaglutide) have a longer half-life (~7 days) than daily options. That affects the washout timeline.
• Actionable takeaway: Tell every member of your surgical team you're on a GLP-1 — including the anesthesiologist — at least 2–4 weeks before your procedure. Then follow the specific washout protocol below.

---

What the New Research Actually Found

A 2025 study indexed on PubMed (PMID 41483457) looked directly at whether GLP-1 receptor agonist use changed outcomes for patients undergoing spine surgery.

The short version: it did not.

Patients on GLP-1 medications did not show significantly worse rates of surgical complications, longer hospital stays, or higher reoperation rates compared to similar patients who were not on these drugs.

This is meaningful. Spine surgery carries real risks — infection, hardware failure, nerve damage, prolonged recovery. If GLP-1 use were quietly making any of those worse, we would want to know. Based on this data, it does not appear to be doing that.

But here is the important context: the study looked at outcomes, not at preparation practices. It does not tell us that patients can ignore their GLP-1 status going into surgery. It tells us that — presumably with appropriate preparation — the results look comparable.

---

Why GLP-1s Still Deserve Special Attention Before Any Surgery

GLP-1 receptor agonists work in part by slowing how fast your stomach empties. This is called gastroparesis, or more precisely, GLP-1-induced delayed gastric emptying. It is one of the reasons these medications reduce appetite so effectively.

Under anesthesia, that slow emptying becomes a problem.

If food or liquid is still sitting in your stomach when you go under, there is a real risk it gets inhaled into your lungs. This is called pulmonary aspiration and it can turn a routine surgery into a serious emergency.

This risk is not hypothetical. The American Society of Anesthesiologists (ASA) updated its guidance specifically because of GLP-1 use. The concern is real enough that anesthesiologists across the country have changed their pre-operative instructions for patients on these medications.

---

The Step-by-Step Protocol: What to Do Before Spine Surgery on a GLP-1

This is the core of this article. Follow these steps, adapt them with your care team, and do not skip the communication part.

Step 1: Tell Every Doctor — Not Just Your Surgeon

Most patients tell their surgeon they are on Ozempic or Wegovy. Fewer think to tell the anesthesiologist. The anesthesiologist is the person managing your airway risk.

At your pre-op appointment, confirm that the following people know you are on a GLP-1:

• Your spine surgeon
• Your anesthesiologist (or the anesthesiology team)
• Your primary care doctor or endocrinologist
• Any nurse doing pre-operative screening

Do this at least 2–4 weeks before your scheduled procedure. Do not wait until the day before.

Step 2: Understand Your Specific Drug's Half-Life

Not all GLP-1s work the same way, and not all of them clear your system at the same speed. This matters for how long before surgery you need to stop taking them.

Here is a simple breakdown:

Medication	Dosing	Approximate Half-Life	General Washout Guidance
Semaglutide (Ozempic, Wegovy)	Weekly injection	~7 days	Stop 1–2 weeks before elective surgery
Tirzepatide (Mounjaro, Zepbound)	Weekly injection	~5 days	Stop 1 week before elective surgery
Liraglutide (Victoza, Saxenda)	Daily injection	~13 hours	Stop at least 24–48 hours before
Dulaglutide (Trulicity)	Weekly injection	~5 days	Stop 1 week before elective surgery

These are general ranges, not your personal instructions. Your specific dose, how long you have been on the medication, and any kidney or liver considerations can all shift these numbers. Use this table as a starting point for the conversation with your doctor — not as a final answer.

Step 3: Get Written Pre-Op Instructions That Specifically Address GLP-1 Use

Generic pre-op instructions ("nothing by mouth after midnight") were written before GLP-1 medications became mainstream. They may not adequately account for delayed gastric emptying.

Ask your anesthesiologist directly: "Given that I'm on [medication name and dose], are my fasting instructions any different from the standard?"

The ASA guidance suggests that patients on GLP-1s who have GI symptoms like nausea, vomiting, or significant bloating in the days leading up to surgery may need extended fasting or additional evaluation. A low-residue diet in the days before surgery is sometimes recommended.

If your care team does not know about GLP-1-specific pre-op considerations, that is useful information. It means you may need to advocate for yourself or ask for a referral to an anesthesiologist with more experience in this area.

Step 4: Do Not Just Stop and Restart Without a Plan

Stopping your GLP-1 medication before surgery has a trade-off: your blood sugar may rise, especially if you have type 2 diabetes. For people using GLP-1s primarily for weight management without diabetes, this is less of a concern. For people managing blood sugar, it requires a backup plan.

Talk to your prescribing doctor about:

• Whether you need temporary blood sugar monitoring while off the GLP-1
• Whether any other medication adjustments are needed during the washout window
• When it is safe to restart after surgery

Do not assume "stop before, restart after" is a complete plan. Get the specifics in writing.

Step 5: Watch for Red Flags in the Days Before Surgery

If you experience any of the following in the 1–2 weeks before your procedure, contact your surgical team immediately:

• New or worsening nausea
• Vomiting
• Significant abdominal bloating
• Inability to tolerate solid food

These are signs of significant gastric slowing and may mean your surgery needs to be rescheduled or your fasting window extended. This is not a reason to panic — it is a reason to communicate early.

---

Common Mistakes Patients Make (And How to Avoid Them)

Mistake #1: Assuming the surgeon handles the GLP-1 conversation. The surgeon is focused on your spine. The anesthesiologist is focused on your airway. Make sure both know.

Mistake #2: Stopping GLP-1s too late. Weekly injectables like semaglutide stay active in your system for about a week after the last dose. Stopping 24 hours before is not the same as stopping 7–10 days before.

Mistake #3: Restarting too soon after surgery. Post-surgical stress, pain medications, and reduced oral intake can all interact badly with GLP-1s in the immediate recovery period. Most guidelines suggest waiting until you are tolerating a regular diet and have confirmed this with your prescribing doctor.

Mistake #4: Not disclosing compounded semaglutide. If you are using a compounded version of a GLP-1 from a telehealth or wellness clinic, it still counts. Tell your surgical team. Some patients hesitate because they think it is a gray area — but from the anesthesiologist's perspective, the mechanism is the same and the risk is the same.

Mistake #5: Ignoring the weight loss itself as a factor. If you have lost significant weight on a GLP-1, your surgical risk profile may actually have improved in meaningful ways — lower blood pressure, better blood sugar, less mechanical stress on the spine. This is part of why the new research may be showing comparable outcomes. Do not overlook the overall health improvement as a genuine factor in your favor.

---

What About Recovery? GLP-1s After Spine Surgery

One emerging concern in the research community is muscle loss during GLP-1-induced weight loss. Lean muscle mass matters a lot for spinal recovery — you need it for physical therapy, for core stability, and for protecting the surgical site.

A 2026 study in a major research journal explored how a compound called 15-PGDH inhibition may support muscle repair during GLP-1-induced weight loss. This is early-stage research, but it signals that the science community is actively aware of the muscle-preservation question.

For practical purposes right now, this means:

• Prioritize protein intake during your recovery window (general guidance from sports medicine typically suggests 1.2–1.6 grams per kilogram of body weight per day during active recovery)
• Work with your physical therapist on resistance-based rehab as soon as your surgeon clears it
• Talk to your doctor about whether your GLP-1 dose needs adjustment during an extended recovery period with reduced appetite and activity

---

Why This Research Matters for People on GLP-1s Long-Term

GLP-1 receptor agonists are no longer a niche medication. Millions of people are on semaglutide or tirzepatide for weight management, metabolic health, and diabetes. As that population grows, more of them will need surgeries — including spine surgeries.

The fear that GLP-1 use automatically puts patients in a higher-risk category has understandably made some patients nervous about their surgery, and some surgeons nervous about operating on them. This new research helps recalibrate that fear.

It does not eliminate the need for smart preparation. It does confirm that smart preparation appears to be working.

The goal is not to stop your GLP-1 and hope for the best. The goal is to communicate clearly, time your washout correctly, and walk into surgery with your entire team informed and aligned.

---

FAQ

Do I have to stop Ozempic or Wegovy before spine surgery? Most anesthesiologists currently recommend stopping weekly GLP-1 injections like semaglutide (Ozempic, Wegovy) approximately 1–2 weeks before elective surgery. This is specifically to reduce the risk of food or liquid remaining in the stomach during anesthesia. Talk to your anesthesiologist for guidance specific to your dose and health situation.

Will being on a GLP-1 make my spine surgery more dangerous? Based on a recently published study (PMID 41483457), patients on GLP-1 receptor agonists did not show significantly worse spine surgery outcomes compared to patients not on these medications. The main risk to manage is anesthesia-related, specifically delayed gastric emptying. With proper preparation, that risk can be addressed.

What if I use a compounded GLP-1 from a telehealth clinic? It still matters and still needs to be disclosed. The mechanism — and the delayed gastric emptying risk — is the same regardless of whether you are using a brand-name or compounded formulation. Tell your anesthesiologist and surgeon.

Can I restart my GLP-1 right after spine surgery? Generally, no — not immediately. Most physicians recommend waiting until you are tolerating a regular diet and have confirmed with your prescribing doctor. Pain medications, surgical stress, and reduced food intake in the early recovery period can all interact with GLP-1 therapy in ways that need to be managed carefully.

Does losing weight on a GLP-1 help or hurt my spine surgery outcome? The weight loss itself is likely a net positive for surgical outcomes — less mechanical load, better metabolic health, lower blood pressure. The trade-off to manage is muscle preservation during recovery. Focus on protein intake and engage in supervised physical therapy as soon as you are cleared.

---

The Bottom Line: Smart Protocol, Not Panic

The headline finding here is genuinely good news: taking a GLP-1 medication does not appear to make spine surgery outcomes worse.

But "good news" is not the same as "do nothing differently." The preparation steps — stopping on time, informing your full surgical team, managing blood sugar during the washout, and protecting muscle during recovery — all still matter.

If you are on semaglutide, tirzepatide, or any other GLP-1 and have a spine surgery scheduled, print this article, share the key steps with your care team, and make sure everyone is on the same page before your procedure date.

That is how reassuring research becomes a reassuring outcome.

---

Medical Disclaimer: The information on this website is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol, medication, or supplement regimen. Individual results vary. The author shares personal experience and published research — not medical recommendations.

---

Sources

1. GLP-1 receptor agonist use and spine surgery outcomes — PubMed, 2025
2. 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss — PubMed, 2026
3. Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea — Current Opinion in Endocrinology, Diabetes, and Obesity, 2026
4. Ocular Outcomes with Tirzepatide versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes — Ophthalmology Retina, 2026
5. American Society of Anesthesiologists guidance on GLP-1 receptor agonists and perioperative fasting — ASA, 2023